For example, genetic risk alleles (e.g., 148Met in the patatin-like phospholipase domain-containing protein 3, PNPLA3) in NAFLD are associated with protecting function in CVDs (17). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.